West Nile Virus Envelope Protein (CT) Blocking Peptide

West Nile Virus Envelope Protein (CT) Blocking Peptide

Product No.: W153

[product_table name="All Top" skus="W153"]

- -
- -
Target
West Nile Virus Envelope Protein
Product Type
Blocking Peptide
Alternate Names
WNV ENV
Applications
ELISA Indirect
,
N

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Virus
Product Concentration
0.2 mg/ml
Amino Acid Location
14 amino acids near the center of West Nile Virus Envelope protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
West Nile Virus Envelope Protein peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
Research Area
Category B Pathogens
.
Infectious Disease
.
Viral
.
West Nile

References & Citations

1. Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interferon & Cyto. Res. 2004; 24:439-54 2. Weisz A, Marx P, Sharf R, et al. The human interferon consensus sequence binding protein (H-ICSBP) is a negative regulator of enhancer elements common to interferon inducible genes. J. Biol. Chem. 1992; 267:25589-96. 3. Nelson N, Marks MS, Driggers PH, et al. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol. 1993; 13:588-99. 4. Tsujimura H, Tamura T, Kong HJ, et al. Toll-like receptor 9 signaling activates NF-κB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 2004; 172:6820-7.
Indirect Elisa Protocol
N

Certificate of Analysis

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.